Clinical Trial Update: Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating rosiglitazone added to clozapine in schizophrenia patients with glucose metabolism impairment; the study was completed and results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Clozapine (Clozapine)
• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2013-03-06